232 related articles for article (PubMed ID: 32448773)
1. Heart rate outcomes with concomitant parenteral calcium channel blockers and beta blockers in rapid atrial fibrillation or flutter.
Alowais SA; Hayes BD; Wilcox SR; Le J; Koehl JL; Fuh L
Am J Emerg Med; 2021 Jun; 44():407-410. PubMed ID: 32448773
[TBL] [Abstract][Full Text] [Related]
2. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
Atzema CL; Austin PC
Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
Bosch NA; Rucci JM; Massaro JM; Winter MR; Quinn EK; Chon KH; McManus DD; Walkey AJ
Chest; 2021 Apr; 159(4):1452-1459. PubMed ID: 33619010
[TBL] [Abstract][Full Text] [Related]
4. Comparison between beta-blockers and calcium channel blockers in patients with atrial fibrillation according to renal function.
Parada Barcia JA; Raposeiras Roubin S; Fernández DG; García AG; Otero CI; González Bermúdez I; Íñiguez Romo A; Abu-Assi E
Clin Cardiol; 2024 May; 47(5):e24257. PubMed ID: 38664980
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness.
Scheuermeyer FX; Grafstein E; Stenstrom R; Christenson J; Heslop C; Heilbron B; McGrath L; Innes G
Acad Emerg Med; 2013 Mar; 20(3):222-30. PubMed ID: 23517253
[TBL] [Abstract][Full Text] [Related]
6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
7. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
Lévy S
Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous beta-blockers in acute atrial fibrillation and flutter is dependent on beta-1 selectivity: a systematic review and meta-analysis of randomised trials.
Perrett M; Gohil N; Tica O; Bunting KV; Kotecha D
Clin Res Cardiol; 2024 Jun; 113(6):831-841. PubMed ID: 37658166
[TBL] [Abstract][Full Text] [Related]
10. Impact of intravenous calcium with diltiazem for atrial fibrillation/flutter in the emergency department.
Rossi N; Allen B; Hailu K; Kamataris K; Ryan C
Am J Emerg Med; 2023 Feb; 64():57-61. PubMed ID: 36442264
[TBL] [Abstract][Full Text] [Related]
11. Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease.
You SC; An MH; Yoon D; Ban GY; Yang PS; Yu HT; Park RW; Joung B
Heart Rhythm; 2018 Dec; 15(12):1825-1832. PubMed ID: 30509364
[TBL] [Abstract][Full Text] [Related]
12. Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department.
Hasbrouck M; Nguyen TT
Am J Emerg Med; 2022 Aug; 58():39-42. PubMed ID: 35623182
[TBL] [Abstract][Full Text] [Related]
13. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
Fromm C; Suau SJ; Cohen V; Likourezos A; Jellinek-Cohen S; Rose J; Marshall J
J Emerg Med; 2015 Aug; 49(2):175-82. PubMed ID: 25913166
[TBL] [Abstract][Full Text] [Related]
14. A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Yamashita T; Nakasu Y; Mizutani H; Sumitani K
J Cardiol; 2019 Nov; 74(5):418-425. PubMed ID: 31255463
[TBL] [Abstract][Full Text] [Related]
15. Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers.
Koldenhof T; Van Gelder IC; Crijns HJ; Rienstra M; Tieleman RG
Heart; 2023 Nov; 109(23):1759-1764. PubMed ID: 37433659
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Rate Control Efficacy between beta-blockers and Calcium Channel Blockers in Patients Hospitalized with Atrial Fibrillation.
Sherf Y; Avital D; Geva Robinson S; Arotsker N; Waldman Radinsky L; Chen Hendel E; Braiman D; Hayadri A; Akselrod D; Schlaeffer-Yosef T; Abu Fraiha Y; Toledano R; Maimon N
Isr Med Assoc J; 2022 Nov; 24(11):752-756. PubMed ID: 36436044
[TBL] [Abstract][Full Text] [Related]
17. Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department.
Hines MC; Reed BN; Ivaturi V; Bontempo LJ; Bond MC; Hayes BD
Am J Health Syst Pharm; 2016 Dec; 73(24):2068-2076. PubMed ID: 27919874
[TBL] [Abstract][Full Text] [Related]
18. Acute ventricular rate control in atrial fibrillation and atrial flutter.
Khan IA; Nair CK; Singh N; Gowda RM; Nair RC
Int J Cardiol; 2004 Oct; 97(1):7-13. PubMed ID: 15336799
[TBL] [Abstract][Full Text] [Related]
19. Comparative persistence on β-blockers versus calcium channel blockers for ventricular rate control in nonelderly patients with atrial fibrillation.
Desai VC; Kelton CM; Metzger AH; Cavanaugh TM; Guo JJ; Heaton PC
Ann Pharmacother; 2014 Dec; 48(12):1570-9. PubMed ID: 25280975
[TBL] [Abstract][Full Text] [Related]
20. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
